Lykon

Lykon

An innovative health care company that provides digital health coaching based on Biomarker analysis. Learn more

Financials

Estimates*

Edit
Revenues, earnings & profits over time
USD20182019202020212023
Revenues-2.5m4.2m-9.3m
% growth--68 %--
Profit(1.2m)(2.0m)(2.4m)(3.7m)-
% profit margin-(79 %)(57 %)--
  • Edit
DateInvestorsAmountRound
-

N/A

-
N/A

N/A

Seed

€6.4m

Seed

N/A

Debt
*

€10.0m

Series A
*

€2.5m

Valuation: €50.0m

Early VC
*

N/A

Acquisition
Total FundingAUD32.1m

Recent News about Lykon

Edit
More about Lykoninfo icon
Edit

Lykon operates in the personalized health and wellness market, offering at-home blood and DNA tests to help individuals optimize their diet and nutrient intake. The company serves health-conscious consumers looking to tailor their dietary and lifestyle choices based on their unique genetic and metabolic profiles. Lykon's business model revolves around selling test kits directly to consumers through their website, as well as offering subscription-based services for ongoing health monitoring and personalized recommendations. Revenue is generated from the sale of these test kits and subscription services. The company leverages advanced biotechnology to provide actionable insights, making it easier for clients to achieve their health and wellness goals.

Keywords: personalized health, at-home tests, blood analysis, DNA analysis, diet optimization, nutrient balance, genetic profiling, health monitoring, biotechnology, wellness.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.

Investments by Lykon

Edit
GAIA Nutrition
ACQUISITION by Lykon Jun 2021